Everolimus

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0054-0497
  • Package NDC 0054-0497-13
  • Application number ANDA207486
  • SPL ID 03212bec-ec7b-4045-ac2b-0cc073e92d32
  • SPL set ID 5aaf2fb7-93f6-40d6-941a-9583a3794ce7
  • UNII 9HW64Q8G6G
  • RxCUI 845507
  • RxCUI 845515
  • RxCUI 998189
  • RxCUI 1119400

What the source publishes

Labeler
Hikma Pharmaceuticals USA Inc.
Active ingredients
Everolimus
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0054-0497_03212bec-ec7b-4045-ac2b-0cc073e92d32
{
  "name": "Everolimus",
  "splId": "03212bec-ec7b-4045-ac2b-0cc073e92d32",
  "labels": [
    {
      "setId": "5aaf2fb7-93f6-40d6-941a-9583a3794ce7",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5aaf2fb7-93f6-40d6-941a-9583a3794ce7",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5aaf2fb7-93f6-40d6-941a-9583a3794ce7"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Hikma Pharmaceuticals USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (0054-0497-13)",
      "package_ndc": "0054-0497-13",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210212"
    }
  ],
  "productId": "0054-0497_03212bec-ec7b-4045-ac2b-0cc073e92d32",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "0054-0497",
  "deaSchedule": null,
  "genericName": "Everolimus",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "EVEROLIMUS",
      "strength": "7.5 mg/1"
    }
  ],
  "applicationNumber": "ANDA207486",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200608",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175605",
      "N0000175076",
      "N0000182141",
      "N0000182137",
      "N0000175625",
      "N0000175624",
      "N0000175550"
    ],
    "upc": [
      "0300540481131",
      "0300540482138",
      "0300540480134"
    ],
    "unii": [
      "9HW64Q8G6G"
    ],
    "rxcui": [
      "845507",
      "845515",
      "998189",
      "1119400"
    ],
    "spl_set_id": [
      "5aaf2fb7-93f6-40d6-941a-9583a3794ce7"
    ],
    "pharm_class_pe": [
      "Decreased Immunologic Activity [PE]"
    ],
    "pharm_class_epc": [
      "Kinase Inhibitor [EPC]",
      "mTOR Inhibitor Immunosuppressant [EPC]"
    ],
    "pharm_class_moa": [
      "Protein Kinase Inhibitors [MoA]",
      "Cytochrome P450 3A4 Inhibitors [MoA]",
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "mTOR Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Hikma Pharmaceuticals USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0054-0497_03212bec-ec7b-4045-ac2b-0cc073e92d32"